China SXT Pharmaceuticals, Inc.
General ticker "SXTC" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $358.7M (TTM average)
China SXT Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -34.0%.
Estimated limits based on current volatility of 4.4%: low 2.42$, high 2.64$
Factors to consider:
- Total employees count: 96 as of 2019
Short-term SXTC quotes
Long-term SXTC plot
Financial data
| YTD | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| Operating Revenue | $1.93MM | $1.74MM | $1.07MM |
| Operating Expenses | $4.44MM | $4.42MM | $8.20MM |
| Operating Income | $-2.52MM | $-2.68MM | $-7.12MM |
| Non-Operating Income | $-0.58MM | $-0.62MM | $1.05MM |
| Interest Expense | $0.54MM | $0.65MM | $0.06MM |
| R&D Expense | $0.18MM | $0.19MM | $0.18MM |
| Income(Loss) | $-3.10MM | $-3.30MM | $-6.07MM |
| Taxes | $0.00MM | $0.00MM | $0.13MM |
| Net Income(Loss)* | $-3.10MM | $-3.30MM | $-6.21MM |
| Stockholders Equity | $13.93MM | $15.44MM | $29.71MM |
| Inventory | $0.81MM | $0.83MM | $2.96MM |
| Assets | $23.13MM | $21.66MM | $34.75MM |
| Operating Cash Flow | $-1.93MM | $-2.35MM | $-4.02MM |
| Capital expenditure | $0.01MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $0.03MM | $0.06MM | $-1.25MM |
| Financing Cash Flow | $-2.62MM | $8.40MM | $14.43MM |
| Earnings Per Share** | $-3.57 | $-8.18 | $-9.13 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.